Calithera begins enrolment for Phase II B-cell lymphoma therapy trial
The Phase II study will assess the single-agent activity of mivavotinib in relapsed/refractory non-GCB/ABC DLBCL patients.

The Phase II study will assess the single-agent activity of mivavotinib in relapsed/refractory non-GCB/ABC DLBCL patients.
The network will progress to support critical research capacity among a national network of over 60 sites with the funding.
The randomised, double-blind, placebo-controlled trial will analyse ATH434 in early-stage MSA patients.
The trial of Bentrio nasal spray in acute Covid-19 patients is being carried out in Bulgaria and North Macedonia.
Digital simulation could help break down healthcare barriers, but experts caution the clinical trials sector to go slow.
ByMapping Endpoints: Most clinical trials for pain still use a zero-to-ten scale as a primary endpoint. Experts are on the…
ByThis collaboration intends to boost clinical research opportunities available to all patients including minorities.
The company plans to make regulatory submissions seeking update to the composition of the booster vaccine to mRNA-1273.214.
Thank you for subscribing to Clinical Trials Arena